Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

NCT05941156 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK T Cell Lymphoma
NK-Cell Leukemia

Interventions

BIOLOGICAL: Anti-CD56 CAR T

Sponsor

The Affiliated Hospital of Xuzhou Medical University